Patients who lose weight slowly through dietary restriction alone rarely report the same level of fatigue or 'brain fog' that some tirzepatide users describe in weeks 410 of therapy, and this subjective difference may reflect the pace at which their antioxidant systems are being challenged
Randomized-clinical trials are needed to assess various interventions combining GLP-1RA with controlled dietary interventions to evaluate health outcomes, such as nutrient status, muscle mass preservation, and overall quality of life
Ozempic is the brand name of a semaglutide manufactured by Novo Nordisk
As the wellness industry moves away from quick fixes and embraces holistic approaches, FuturHealth is at the forefront of this transformation
Thyroid function tests should be performed at baseline, repeated at 812 weeks after starting GLP-1 therapy, then every 36 months during active weight loss
Potential adverse effects, such as mucocutaneous dryness, lipid and liver changes, and teratogenicity, must also be taken into account